fda glp-1 compounding crackdown news october 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement Did the FDA Ban Compounded

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

If you do not have a healthcare provider please go to: Finding a Healthcare Provider Clinical scenario: I am taking Ozempic (semaglutide), and I would like to try to become pregnant soon

This is especially important for blood pressure medications

March 1: The FDA on Friday granted full approval of J&Js Rybrevant in combination with chemotherapy as a first-line treatment for patients with non-small cell lung cancer (NSCLC) EGFR exon 20 insertion mutations, the company announced

doi:10.4103/aja.aja_87_20 Dupont C, Faure C, Daoud F, Gautier B, Czernichow S, Lvy R

Regulation of the pentose phosphate pathway in cancer